Compositions and methods for treating liver diseases with sirnas targeting gpam

Abstract

Disclosed herein are compositions comprising siRNAs capable of downregulating Glycerol-3-Phosphate Acyltransferase, Mitochondrial (GPAM) gene expression or a variant thereof. Also disclosed herein are methods of using such compositions in the treatment of a liver disease or injury, such as fatty …